SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

29 hedge funds and large institutions have $1.55M invested in Seelos Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1
+$188K
2
+$166K
3
+$141K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$67.7K
5
MWM
Modera Wealth Management
New Jersey
+$51.9K

Top Sellers

1
-$422K
2
-$56.3K
3
-$55.6K
4
Morgan Stanley
Morgan Stanley
New York
-$8.4K
5
Two Sigma Investments
Two Sigma Investments
New York
-$7.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$260
27
$219
28
$118
29
$51
30
$30
31
$19
32
$17
33
$9
34
$8
35
$2
36
–
37
–
38
–
39
–
40
–
41
–
42
–
1
2